Viewing Study NCT00132067


Ignite Creation Date: 2025-12-25 @ 12:52 AM
Ignite Modification Date: 2026-01-01 @ 7:52 AM
Study NCT ID: NCT00132067
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2005-08-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2012-02667
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NETWORK View